Clinical Trial Update: Safety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer) [Phase 4]

View source ↗

Summary

Phase 4 trial update on Acthar Gel for inflammation of the eye's uvea, with terminated status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panuveitis
• Uveitis
• Uveitis Intermediate
• Uveitis Posterior

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Mallinckrodt | Conditions: Uveitis, Posterior, Uveitis, Intermediate | Phase 4 | Status: TERMINATED | Results posted: 2021-08-03